CLINICOPATHOLOGICAL VARIABLES PREDICTIVE OF CLINICAL OUTCOME IN PATIENTS WITH FIGO STAGE IB2-IIB CERVICAL CANCER TREATED WITH CISPLATIN-BASED NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL HYSTERECTOMY